ENGITIX

• 72110 - Research and experimental development on biotechnology

Engitix was created in 2016 to commercialise cutting-edge ECM research at the Institute for Liver and Digestive Health, Division of Medicine, University College London (UCL) and is now a growing biotechnology company with over 60 employees... Engitix has an 8,000 square feet facility of purpose-designed office and laboratory space that houses the latest state-of-the-art research instruments and tools. Located at the Westworks building in the prestigious new life science cluster at White City Place, London, UK, we provide a stimulating and innovative research environment with excellent networking opportunities... We are developing a broad pipeline of in house and partnered programmes in fibrosis and solid tumours by leveraging the power of our human extracellular matrix (ECM)-based discovery platform. The ECM provides cells not only with structural support but with a bioactive environment that promotes physiological and pathological processes.

Also known as: ENGITIX LIMITED, Engitix Ltd

Registration numbers: 10290441 (CH)

Primary location: London United Kingdom